Foundation Medicine Gets $111.5M Genomic Profiling Contract From VA Department

Feb 05, 2019

NEW YORK (GenomeWeb) – Foundation Medicine said today that it has won a nationwide contract from the US Department of Veterans Affairs National Precision Oncology Program to provide comprehensive genomic profiling for eligible veterans with advanced cancer.

The estimated contract award is $111.5 million over an anticipated period of five years, according to the Cambridge, Massachusetts-based company.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Menu

Foundation Medicine Gets $111.5M Genomic Profiling Contract From VA Department

To read the full story....

Breaking News

NICE Guidance Recommends Amgen's Blincyto for ALL Patients in Remission

Japanese Regulators Approve Invivoscribe Assay as CDx for Daiichi Sankyo AML Drug

Resolution Bioscience, Janssen Partner to Develop CDx for Niraparib in Prostate Cancer

AstraZeneca, Merck's Lynparza, Myriad Genetics' BRCA Test Approved in Japan

Japan's National Cancer Center Adopts Qiagen Bioinformatics Platform for Precision Med Program

Roche's Rozlytrek Nets Japanese Approval in NTRK-Positive Pan Cancer Indication

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

What's Popular?

Next-Generation Sequencing of Pediatric Cancer Patients Could Transform Treatment Paradigms

Resolution Bioscience, Janssen Partner to Develop CDx for Niraparib in Prostate Cancer

Japan's National Cancer Center Adopts Qiagen Bioinformatics Platform for Precision Med Program

Japanese Regulators Approve Invivoscribe Assay as CDx for Daiichi Sankyo AML Drug

AstraZeneca, Merck's Lynparza, Myriad Genetics' BRCA Test Approved in Japan

Sponsorships